Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to establish state-of-the-art Tissue Mapping Centers (TMCs) that will generate a high-resolution, high-content, multiscale atlas of a non-diseased human organ. Centers will be expected to integrate and optimize all parts of the data generation pipeline, from tissue collection and preservation through to data integration,analysis and interpretation. Centers will also be expected to work closely with the other funded projects as part of the Human BioMolecular Atlas Program to catalyze development of a framework for mapping the human body in 3D with high resolution.

Companion FOA: RFA-RM-21-027 , U01 Research Project (Cooperative Agreements)


  • Letters of Intent Receipt Date(s): Oct. 19, 2021
  • Application Due Date(s): Nov. 19, 2021

RFA-RM-21-026 Expiration Date: November 20, 2021

Agency Website

Areas of Interest


Amount Description

NIH intends to fund an estimate of 5-7 awards, corresponding to a total of approximately $12M for fiscal year 2022, $13.5M for fiscal year 2023, $15M for fiscal year 2024 and $3M for fiscal year 2025. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

November 19, 2021